COMMUNIQUÉS West-GlobeNewswire

Wave Life Sciences Reports Fourth Quarter and Full-Year 2017 Financial Results and Provides Business Update
12/03/2018
Initiated three clinical trials in 2017 and on track to deliver three additional development programs in 2018 Neurology pipeline growing; candidate in spinocerebellar ataxia type 3 to be named by year end 2018 CAMBRIDGE [...]
Krystal Biotech Reports 2017 Financial Results and Business Progress
12/03/2018
IND for KB103 to treat Dystrophic Epidermolysis Bullosa (DEB) to be filed in March 2018 IND for KB105 to treat Lamellar Ichthyosis to be filed in Q4 2018 Company was granted composition of matter and method of use [...]
Celsion Corporation to Present at Upcoming Investor Conferences
12/03/2018
LAWRENCEVILLE, N.J., March 12, 2018 (GLOBE NEWSWIRE) -- -- Celsion Corporation (NASDAQ: CLSN), an oncology drug development company, today announced that Michael Tardugno, Chairman, President and Chief Executive Officer [...]
Fibrocell to Host Conference Call and Webcast on Monday, March 19, 2018 to Discuss 2017 Financial Results and Recent Highlights
12/03/2018
EXTON, Pa., March 12, 2018 (GLOBE NEWSWIRE) -- Fibrocell Science, Inc. (NASDAQ: FCSC ), a gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases, will [...]
Inovio Pharmaceuticals to Report Fourth Quarter and Year End 2017 Financial Results on March 14, 2018
12/03/2018
PLYMOUTH MEETING, Pa., March 12, 2018 (GLOBE NEWSWIRE) -- Inovio Pharmaceuticals, Inc. (NASDAQ: INO ) announced today that it will host a conference call and live webcast to report its 2017 fourth quarter and year end [...]
Mersana Appoints David A. Spellman as Chief Financial Officer
12/03/2018
CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN ), a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates ( [...]
Global Blood Therapeutics Announces Full Exercise of Underwriter’s Option to Purchase Additional Shares
12/03/2018
SOUTH SAN FRANCISCO, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (Nasdaq: GBT ), a clinical-stage biopharmaceutical company dedicated to discovering, developing and commercializing [...]
Delcath to Present at 30th Annual Roth Conference
12/03/2018
NEW YORK, March 12, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB:DCTH), an interventional oncology Company focused on the treatment of primary and metastatic liver cancers, announces that Jennifer K. Simpson, [...]
Rockwell Medical Schedules Year End 2017 Earnings Call
12/03/2018
WIXOM, Mich., March 12, 2018 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI ), a fully-integrated biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with [...]
Anthera Pharmaceuticals Reports Top Line Data from the RESULT Phase 3 Clinical Study of Sollpura
12/03/2018
Sollpura did not achieve the primary endpoint of the coefficient of fat absorption (“CFA”) Sollpura did achieve the secondary endpoint of coefficient of nitrogen absorption (“CNA”) Further development of Sollpura to be [...]
Extendicare Announces Appointment of Michael Guerriere to Board of Directors
12/03/2018
MARKHAM, Ontario, March 12, 2018 (GLOBE NEWSWIRE) -- Extendicare Inc. (“Extendicare” or the “Company”) (TSX: EXE ) today announced the appointment of Michael Guerriere to its Board of Directors, effective immediately, [...]
India Globalization Capital Appoints Carrolee Barlow, MD, PhD as Advisor to Help Develop Cannabis Related Products for Treating Various End Points of Parkinson’s Disease and Movement Disorders (PDMD)
12/03/2018
BETHESDA, Md., March 12, 2018 (GLOBE NEWSWIRE) -- India Globalization Capital, Inc. (NYSE American:IGC) today announces that Carrolee Barlow, MD, PhD has been appointed to the Company as an Advisor to help develop [...]
Daré Bioscience Announces Exclusive Development and Option Agreement with Orbis Biosciences for Long-acting Injectable Contraceptive
12/03/2018
Advancing 6- and 12- month injectable contraceptive development work carried out to date under a subcontract funded by Family Health International (FHI 360) through a grant from the Bill & Melinda Gates Foundation [...]
Selecta Biosciences Announces First Patient Dosed in Phase 1 Trial of SVP-Rapamycin and LMB-100 Combination Therapy in Mesothelioma
12/03/2018
WATERTOWN, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Selecta Biosciences, Inc. (Nasdaq: SELB ), a clinical-stage biopharmaceutical company focused on unlocking the full potential of biologic therapies by avoiding [...]
Epizyme to Participate in Oppenheimer & Co. 28th Annual Healthcare Conference
12/03/2018
CAMBRIDGE, Mass., March 12, 2018 (GLOBE NEWSWIRE) -- Epizyme, Inc. (NASDAQ: EPZM ), a clinical-stage biopharmaceutical company creating novel epigenetic therapies, today announced that management will present at the [...]
Avivagen Announces Approval from TSX Venture Exchange for Extension of Warrants
12/03/2018
THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. OTTAWA, March 12, 2018 (GLOBE NEWSWIRE) -- [...]
Sienna Biopharmaceuticals Announces First Patient Dosed in Proof-of-Concept Trial of Topical by Design™ JAK Inhibitor SNA-125 for Atopic Dermatitis
12/03/2018
-- Trial to Enroll Approximately 30 Patients with Atopic Dermatitis -- Top-Line Results Expected in Fourth Quarter of 2018 WESTLAKE VILLAGE, Calif., March 12, 2018 (GLOBE NEWSWIRE) -- Sienna Biopharmaceuticals, Inc. ( [...]
PotNetwork Holding Unveils New Products At World’s Premiere Trade Show, ASD Market Week
12/03/2018
FT. LAUDERDALE, Fla., March 12, 2018 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- PotNetwork Holding, Inc. (OTC Pink:POTN) (“Company”), announced today that its wholly owned subsidiary, Diamond CBD, Inc., is currently [...]
Ritter Pharmaceuticals Reports Microbiome Data from Phase 2b Study of RP-G28 Promotes Beneficial Adaptation of the Gut Microbiome
12/03/2018
LOS ANGELES, March 12, 2018 (GLOBE NEWSWIRE) -- Ritter Pharmaceuticals, Inc. (NASDAQ: RTTR ) (“Ritter Pharmaceuticals” or the “Company”), a developer of novel therapeutics that modulate the gut microbiome to treat [...]

Pages